Disease/Infection News

RSS

New technique may accelerate development of novel vaccines

An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.

20 Jan 2016

Profectus begins Phase 1 clinical study of VesiculoVax-vectored Ebola virus vaccine

Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.

19 Jan 2016

Adaptive, light-activated nanotherapy effective against drug-resistant bacteria

In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.

19 Jan 2016

Researchers suggest ways to make TB drugs more efficacious against mutations

Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.

19 Jan 2016

New clinical imaging method may enable doctors to tackle lung infections

A new clinical imaging method developed in collaboration with a University of Exeter academic may enable doctors to tackle one of the main killers of patients with weakened immune systems sooner and more effectively.

19 Jan 2016

WHO confirms new case of Ebola in Sierra Leone, stresses ongoing risk of more flare-ups

A new case of Ebola has been confirmed in Sierra Leone, reflecting the ongoing risk of new flare-ups of the virus in affected countries.

19 Jan 2016

Antivirulence antibiotics could evade resistance longer than traditional antibiotics

We've all seen the headlines. "Man found to be shedding virulent strain of polio"; "Virulent flu strain in Europe hits the economy"; "Most virulent strain of E. coli ever seen contains DNA sequences from plague bacteria."

19 Jan 2016

Researchers confirm that cranberry extract helps fight UTIs in breastfed children under age one

Researchers from the universities of Granada (Spain) and Kvopio (Finland) have confirmed that cranberry extract helps fighting urinary tract infections (UTIs) in breastfed babies under one year of age.

18 Jan 2016

Frozen fecal transplantation effective at providing relief to C. diff patients

Frozen fecal transplantation is effective at providing relief to Clostridium difficile (C. diff) patients, according to a new study co-authored by University of Guelph researchers.

18 Jan 2016

Health Canada approves immunotherapy clinical study to treat Epstein-Barr virus-related lymphomas

Health Canada recently approved, for the first time in Canada, a clinical project for a Phase I study aimed at treating lymphomas associated with the Epstein-Barr virus (EBV) through adoptive cellular immunotherapy that is specific to EBV.

18 Jan 2016

UGA study helps solve mystery of how African trypanosomes communicate

While scientists have known for years that African trypanosomes cause sleeping sickness, they've been left scratching their heads as to how these tiny single-celled organisms communicate. A University of Georgia study, published Jan. 14 in the journal Cell, helps solve this mystery.

18 Jan 2016

Innovative microfiber pad could improve diagnosis of Urinary Tract Infection in infants and elderly patients

Contamination of urine samples from infants and the elderly is so common that physicians often needlessly prescribe broad-spectrum antibiotics prophylactically. Now, a team at The Hebrew University of Jerusalem's BioDesign: Medical Innovation program has developed an innovative microfiber pad that can save time and money in the collection of sterile samples.

18 Jan 2016

Large-scale clinical trial to evaluate dengue vaccine launched in Brazil

A large-scale clinical trial to evaluate whether a candidate vaccine can prevent the mosquito-borne illness dengue fever has been launched in Brazil. The vaccine, TV003, was developed by scientists in the laboratory of Stephen Whitehead, Ph.D., at NIH's National Institute of Allergy and Infectious Diseases (NIAID).

17 Jan 2016

Liberia expects all-clear for Ebola, but further flare-ups are likely, warn experts

Today, the World Health Organization (WHO) officially announces that Liberia is free of Ebola transmission, finally bringing an end to the 2-year epidemic that has infected nearly 29,000 people and claimed more than 11,000 lives across Africa.

14 Jan 2016

Researchers engineer antibodies that could potently neutralize two deadliest strains of Ebola virus

Researchers at Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases have engineered the first antibodies that can potently neutralize the two deadliest strains of the virus that causes Ebola hemorrhagic fever.

13 Jan 2016

UM SOM to team up with industry to develop vaccine for preventing deadly bacterial infections

The Center for Vaccine Development at the University of Maryland School of Medicine will participate in a partnership with industry to develop a vaccine to prevent a group of deadly bacterial infections that occur commonly among hospital patients.

13 Jan 2016

Simple paper test could confirm presence of illnesses even before patients feel symptoms

A multi-disciplinary team of researchers has developed a new diagnostic test that can change the medical landscape by making it possible for patients to quickly determine if they are infected with an illness, using a simple paper test sensitive enough to detect markers of various illnesses using minute amounts of blood, sweat, or other biological material.

13 Jan 2016

Disease/Infection News

New technique may accelerate development of novel vaccines

Profectus begins Phase 1 clinical study of VesiculoVax-vectored Ebola virus vaccine

Adaptive, light-activated nanotherapy effective against drug-resistant bacteria

Researchers suggest ways to make TB drugs more efficacious against mutations

New clinical imaging method may enable doctors to tackle lung infections

WHO confirms new case of Ebola in Sierra Leone, stresses ongoing risk of more flare-ups

Antivirulence antibiotics could evade resistance longer than traditional antibiotics

Researchers confirm that cranberry extract helps fight UTIs in breastfed children under age one

Frozen fecal transplantation effective at providing relief to C. diff patients

Health Canada approves immunotherapy clinical study to treat Epstein-Barr virus-related lymphomas

UGA study helps solve mystery of how African trypanosomes communicate

Innovative microfiber pad could improve diagnosis of Urinary Tract Infection in infants and elderly patients

Large-scale clinical trial to evaluate dengue vaccine launched in Brazil

Liberia expects all-clear for Ebola, but further flare-ups are likely, warn experts

Researchers engineer antibodies that could potently neutralize two deadliest strains of Ebola virus

UM SOM to team up with industry to develop vaccine for preventing deadly bacterial infections

Simple paper test could confirm presence of illnesses even before patients feel symptoms

Estrogen may protect women against flu

Selenium supplementation may have positive and negative effects on immune system

Pre-existing nutritional deficits, immune dysfunction may increase hepatitis E risk during pregnancy

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News